Screening asymptomatic adolescent males for chlamydia

Area of Science:

• Urology
• Infectious Diseases
• Adolescent Health

Background:

• Sexually transmitted infections (STIs) like gonorrhea and chlamydia are prevalent in sexually active adolescents.
• Asymptomatic infections can lead to long-term health complications if not detected and treated.
• Accurate and efficient diagnostic methods are crucial for managing STIs in this demographic.

Purpose of the Study:

• To evaluate the diagnostic performance of chlamydia enzyme immunoassay (EIA) compared to urine analysis for detecting asymptomatic chlamydia urethritis in adolescent males.
• To assess the incidence of gonorrhea and chlamydia in a cohort of asymptomatic, sexually active adolescent males.
• To determine if pyuria is a reliable indicator of STIs in this population.

Main Methods:

• Ninety-seven sexually active, asymptomatic adolescent males (aged 16-21) were enrolled.
• Urine samples were analyzed for pyuria using centrifuged urine and a urine cytometer.
• Chlamydia and gonorrhea testing were performed using culture and chlamydia EIA.

Main Results:

• The incidence of gonorrhea was 5.3% and chlamydia by culture was 12.3%.
• Chlamydia EIA demonstrated superior sensitivity (75%) and specificity (99%) for detecting chlamydia urethritis compared to centrifuged urine (58% sensitivity, 92% specificity) and urine cytometer (58% sensitivity, 91% specificity).
• Pyuria was not a reliable indicator of STIs in asymptomatic males.

Conclusions:

• Chlamydia EIA is a highly sensitive and specific diagnostic method for asymptomatic chlamydia urethritis in adolescent males.
• Chlamydia EIA is a cost-effective, rapid, and acceptable alternative to traditional culture methods.
• The absence of pyuria does not rule out the presence of STIs in asymptomatic adolescent males, highlighting the need for sensitive screening tests.